TWST TWIST BIOSCIENCE CORP revenue, earnings and financials

For the quarter ended June 30, 2026, TWIST BIOSCIENCE CORP reported revenue of $118M (up 23.2% from a year earlier), net income of −$35.1M and diluted EPS of −$0.56; over the last four quarters revenue was $432M and net income −$137M; for the fiscal year ended September 2025 revenue was $377M, up 20.3% on the year before.

TWST annual revenue and earnings

• Fiscal year ended Sep 2025: revenue $377M, gross profit n/a, operating income −$136M, net income −$77.7M (margin -20.6%), EPS −$1.30
• Fiscal year ended Sep 2024: revenue $313M, gross profit n/a, operating income −$221M, net income −$209M (margin -66.7%), EPS −$3.60
• Fiscal year ended Sep 2023: revenue $245M, gross profit n/a, operating income −$217M, net income −$205M (margin -83.5%), EPS −$3.60
• Fiscal year ended Sep 2022: revenue $204M, gross profit n/a, operating income −$235M, net income −$218M (margin -107.0%), EPS −$4.04
• Fiscal year ended Sep 2021: revenue $132M, gross profit n/a, operating income −$153M, net income −$152M (margin -114.9%), EPS −$3.15

TWST quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $118M (up 23.2% year over year), net income −$35.1M, EPS −$0.56
• Quarter ended Mar 31, 2026: revenue $111M (up 19.3% year over year), net income −$44.0M, EPS −$0.71
• Quarter ended Dec 31, 2025: revenue $104M (up 16.9% year over year), net income −$30.5M, EPS −$0.50
• Quarter ended Sep 30, 2025 (from the annual report): revenue $99.0M (up 16.9% year over year), net income −$27.1M, EPS −$0.44
• Quarter ended Jun 30, 2025: revenue $96.1M (up 17.9% year over year), net income $20.4M, EPS $0.33
• Quarter ended Mar 31, 2025: revenue $92.8M (up 23.2% year over year), net income −$39.3M, EPS −$0.66
• Quarter ended Dec 31, 2024: revenue $88.7M (up 24.1% year over year), net income −$31.6M, EPS −$0.53
• Quarter ended Sep 30, 2024 (from the annual report): revenue $84.7M (up 26.5% year over year), net income −$34.7M, EPS −$0.59
• Quarter ended Jun 30, 2024: revenue $81.5M (up 27.8% year over year), net income −$85.6M, EPS −$1.47
• Quarter ended Mar 31, 2024: revenue $75.3M (up 25.1% year over year), net income −$45.5M, EPS −$0.79
• Quarter ended Dec 31, 2023: revenue $71.5M (up 31.8% year over year), net income −$43.0M, EPS −$0.75
• Quarter ended Sep 30, 2023 (from the annual report): revenue $66.9M (up 16.8% year over year), net income −$46.2M, EPS −$0.81
• Quarter ended Jun 30, 2023: revenue $63.7M (up 13.6% year over year), net income −$57.4M, EPS −$1.01
• Quarter ended Mar 31, 2023: revenue $60.2M (up 25.0% year over year), net income −$59.2M, EPS −$1.04
• Quarter ended Dec 31, 2022: revenue $54.2M (up 29.1% year over year), net income −$41.8M, EPS −$0.74
• Quarter ended Sep 30, 2022 (from the annual report): revenue $57.3M, net income −$51.1M, EPS −$0.92
• Quarter ended Jun 30, 2022: revenue $56.1M (up 60.2% year over year), net income −$60.5M, EPS −$1.08
• Quarter ended Mar 31, 2022: revenue $48.1M (up 54.2% year over year), net income −$60.7M, EPS −$1.13
• Quarter ended Dec 31, 2021: revenue $42.0M, net income −$45.6M, EPS −$0.91
• Quarter ended Jun 30, 2021: revenue $35.0M, net income −$40.0M, EPS −$0.82

TWST cash flow, buybacks and dividends

• Fiscal year ended Sep 2025: operating cash flow −$47.6M, share buybacks n/a
• Fiscal year ended Sep 2024: operating cash flow −$64.1M, share buybacks n/a
• Fiscal year ended Sep 2023: operating cash flow −$142M, share buybacks n/a
• Fiscal year ended Sep 2022: operating cash flow −$124M, share buybacks n/a
• Fiscal year ended Sep 2021: operating cash flow −$112M, share buybacks n/a

TWST balance sheet

• Jun 30, 2026: cash $117M, total assets $672M, total liabilities $227M, shareholders' equity $446M
• Mar 31, 2026: cash $123M, total assets $676M, total liabilities $221M, shareholders' equity $455M
• Dec 31, 2025: cash $149M, total assets $638M, total liabilities $182M, shareholders' equity $456M
• Sep 30, 2025: cash $183M, total assets $642M, total liabilities $169M, shareholders' equity $473M
• Jun 30, 2025: cash $201M, total assets $644M, total liabilities $165M, shareholders' equity $478M
• Mar 31, 2025: cash $210M, total assets $596M, total liabilities $156M, shareholders' equity $440M
• Dec 31, 2024: cash $221M, total assets $609M, total liabilities $153M, shareholders' equity $456M
• Sep 30, 2024: cash $226M, total assets $614M, total liabilities $142M, shareholders' equity $473M

What is TWST's revenue?

TWIST BIOSCIENCE CORP reported $432M of revenue over its last four quarters, through June 30, 2026.

Is TWST profitable?

No. TWIST BIOSCIENCE CORP lost $137M over the last four quarters.

What is TWST's EPS?

Diluted earnings per share over the last four quarters were −$2.21; −$0.56 in the latest quarter.

TWST ownership and insider trades · All stocks